Therapeutic efficacy of tofacitinib in PDSAg-induced chronic experimental autoimmune uveitis in Wistar rat
Oral tofacitinib delayed uveitis onset and reduced clinical and histological findings, suggesting its potential as an alternative treatment for uveitis.
Authors
- Can Erzık (ORCID: https://orcid.org/0000-0002-7914-1169)
- Hande Çeliker (ORCID: https://orcid.org/0000-0002-1683-0725)
- Haner Di̇reskeneli̇ (ORCID: https://orcid.org/0000-0003-2598-5806)
- İrem Peker Eyüboğlu (ORCID: https://orcid.org/0000-0003-0764-9841)
- Özlem Tuğçe Çilingir‐Kaya (ORCID: https://orcid.org/0000-0002-2591-9174)
- Berru Yargı Özkoçak (ORCID: https://orcid.org/0000-0002-6801-6178)
Institutions
- Sağlık Bilimleri Üniversitesi (TR)
- Istanbul Eye Hospital (TR)
- Marmara University (TR)
Publication Details
- Journal
- Immunopharmacology and Immunotoxicology
- Published
- 2025-05-28
- DOI
- https://doi.org/10.1080/08923973.2025.2508278
- Primary Topic
- Ocular Diseases and Behçet’s Syndrome
- Type
- article
- Field-Weighted Citation Impact
- 0.00